A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Kimberly Loo et al.|Nature Medicine|2018Cited by 1k
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell ImmunityMikhail Binnewies, Matthew F. Krummel, Adriana M. Mujal et al.|Cell|2019Cited by 617
Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J. Combes, Sima P. Porten, Bushra Samad et al.|Cell|2021Cited by 172
Translating inflammation: characterization of host protein synthesis during bacterial infectionsKevin C. Barry|eScholarship (California Digital Library)|2015Cited by 0